secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001493152-26-008065
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio shareholders approve 100M share increase and reverse stock split authorization
--------------------------------------------------------------------------------

- Shareholders approved amending 2024 Omnibus Incentive Plan to add 100,000,000 shares, effective Feb 19, 2026.
- Shareholders authorized reverse stock split at ratio between 1:25 and 1:85, with exact ratio set by Board in its discretion.
- Both proposals passed with strong support: 147.8M for plan amendment; 176.3M for reverse split (no broker non-votes on split).
- 182.4 million shares were represented at the special meeting, ~90.5% of outstanding 201.5M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226008065/0001493152-26-008065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226008065/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer